A nanocarbon-enabled hybridization strategy to construct pharmacologically cooperative therapeutics for augmented anticancer efficacy-Reference-Cited by-同舟云学术

A nanocarbon-enabled hybridization strategy to construct pharmacologically cooperative therapeutics for augmented anticancer efficacy

Published:2024 Issue: Volume: Page:
ISSN:2041-6520
Container-title:Chemical Science
language:en
Short-container-title:Chem. Sci.

Author:

Wang Huan¹^ORCID,Liu Xinchen²,Yan Xiangyu³,Du Yong³,Pu Fang¹,Ren Jinsong¹^ORCID,Qu Xiaogang¹^ORCID

Affiliation:

1. State Key Laboratory of Rare Earth Resources Utilization and Laboratory of Chemical Biology, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin 130022, P. R. China

2. Jilin Provincial Key Laboratory of Tooth Development and Bone Remodeling, Hospital of Stomatology, Jilin University, Changchun, Jilin 130021, P. R. China

3. State Key Laboratory of Powder Metallurgy, Central South University, Changsha, Hunan 410083, P. R. China

Abstract

We propose a nanocarbon-enabled hybridization strategy to construct pharmacologically cooperative nanodrugs for augmented cancer therapy based on pharmacophore hybridization in medicinal chemistry and the synthetic principles of nanocarbons.

Funder

National Key Research and Development Program of China

National Natural Science Foundation of China

Jilin Provincial Scientific and Technological Development Program

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/SC/D4SC05280C

Reference54 articles.

1. Molecular Hybridization: A Useful Tool in the Design of New Drug Prototypes

2. Hybrid Molecules with a Dual Mode of Action: Dream or Reality?

3. Chemical Evolution of Natural Product Structure

4. Amplification of oxidative stress by a dual stimuli-responsive hybrid drug enhances cancer cell death

5. A Synthetic Hybrid Molecule for the Selective Removal of Human Pluripotent Stem Cells from Cell Mixtures